Share This Link

A sternal incision is used for a thoracotomy or cardiac surgery involving a median sternotomy. A lobectomy typically requires a posterolateral or axillary thoracotomy incision, not a sternal incision, making this option incorrect regarding the expected surgical approach.

While postoperative pain is expected, the question asks for a specific procedure-related expectation. Moderate pain is a generic postoperative outcome for many surgeries, whereas the presence of a chest tube is a specific, essential requirement following a lobectomy.

Pulmonary function studies are used to evaluate lung capacity and airway obstruction preoperatively to assess surgical risk. They are not a routine postoperative procedure immediately following a lobectomy, as the focus is on lung re-expansion and drainage.

Finasteride works by inhibiting the conversion of testosterone to dihydrotestosterone, which takes time to reduce prostate size. Patients should be informed that it may take 6 to 12 months to see significant symptom improvement, not one week.

Finasteride actually decreases prostate-specific antigen levels by approximately 50 percent. It is crucial for patients to understand that their PSA baseline will change, and clinicians must adjust for this reduction when interpreting future screening results for prostate cancer.

There is no clinical interaction between finasteride and grapefruit juice. While grapefruit juice interacts with many medications processed by the CYP3A4 enzyme system, it is not a contraindicated substance for clients taking this specific medication for prostate enlargement.

Progesterone is not the standard treatment for estrogen receptor-positive tumors. While progestins have been used in some metastatic breast cancer cases, they do not directly block the specific estrogen-driven signaling pathways that promote growth in these tumor types.

Administering estrogen would stimulate the growth of estrogen receptor-positive cancer cells. Estrogen acts as a mitogen in these tissues; therefore, providing supplemental estrogen is contraindicated and would likely accelerate disease progression rather than provide any therapeutic benefit here.

While oophorectomy may be used to reduce estrogen levels in premenopausal women, it is not the most common primary treatment compared to pharmacotherapy like tamoxifen. It is an invasive surgical procedure reserved for specific circumstances rather than initial management.

Palliative care is not synonymous with stopping treatment. Patients may continue curative-intent treatments concurrently with palliative care. Equating palliative care solely with giving up or stopping all medical efforts demonstrates a misunderstanding of its role in symptom management.

Palliative care does not prioritize prolonging life, which is the goal of curative or life-prolonging care. While some patients may live longer due to improved symptom control, the focus remains on comfort and quality of life rather than extending survival.

Seeking a second opinion is an action related to curative treatment planning. It does not reflect an understanding of palliative care, which is a supportive approach designed to manage symptoms and distress rather than confirming a diagnosis or choosing treatment strategies.

Hospice care is frequently provided in the patient's home or current place of residence. Admission to a long-term care facility is not a requirement; the goal is to provide comfort wherever the patient feels most at ease and supported.

Hospice care has strict eligibility criteria, typically requiring a physician's certification that the patient has a terminal illness with a life expectancy of six months or less if the disease follows its natural course, rather than being universally available.

Hospice care marks a shift from curative to comfort-focused care. The philosophy of hospice is to forgo aggressive life-prolonging or curative treatments, such as aggressive chemotherapy or further attempts to eliminate the cancer, to concentrate entirely on the patient's quality of life.

Explaining specific medical treatment options based on staging exceeds the nursing scope of practice. The prescribing provider is legally responsible for discussing the medical prognosis, staging, and oncological treatment plan options with the newly diagnosed client.

Providing uncurated internet articles can overwhelm a newly diagnosed client and cause unnecessary anxiety. Information regarding staging and malignancy should be tailored individually by the healthcare team rather than gathered from general online resources.

Assuring the client that the provider will explain everything is a nontherapeutic response that dismisses the client's current concerns. It minimizes their immediate anxiety and cuts off further communication or emotional expression with the nurse.

Limiting fluid intake to 1 liter daily is insufficient and increases urinary supersaturation. Clients with nephrolithiasis should consume at least 2.5 to 3 liters of fluid daily to maintain high urine volume and dilute stone-forming minerals.

Recommending sugar-sweetened beverages increases the risk of stone formation. High fructose intake elevates urinary calcium, oxalate, and uric acid excretion, which directly promotes the crystallization of renal calculi within the urinary tract.

Avoiding nonsteroidal anti-inflammatory drugs is incorrect because they are first-line agents for renal colic pain. These medications inhibit prostaglandin synthesis, which reduces ureteral smooth muscle spasms and localized inflammation caused by stone movement.